ArticleScientific reports2025
Comparing quality of life methadone and buprenorphine for opioid substitution treatment in Iran.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characteristics and risk factors of opioid poisoning in opioid-dependent individuals using their primary opioid of dependence: a registry-based study.International journal of emergency medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opioid use disorder (OUD) is a significant global health issue, with harm reduction strategies like Opioid Substitution Treatment (OST) playing a crucial role in improving quality of life (QoL) for affected individuals. In Iran, Methadone Maintenance Treatment (MMT) and Buprenorphine Maintenance Treatment (BMT) have been implemented for over two decades. This study aims to compare the QoL outcomes between these two treatment modalities among opioid-dependent individuals in three outpatient OST clinics. The World Health Organization Quality of Life - Brief Version (WHOQOL-BREF) questionnaire was utilized to evaluate QoL in domains of physical health, psychological health, social relationships, environment, and general health. QoL was compared between patients receiving methadone and buprenorphine while considering demographic characteristics and treatment duration. Multivariate linear regression analysis identified factors associated with QoL. The study included 200 participants with a mean age of 42.7, comprising 103 individuals treated with buprenorphine and 97 treated with methadone. Buprenorphine-treated patients were more likely to be married, female, younger, and have shorter treatment durations. Methadone-treated patients reported higher QoL in physical health (P = 0.001) and social relationship (P = 0.002) domains, while buprenorphine-treated patients reported better environmental health (P < 0.001). No significant differences were found in psychological domains. These QoL differences remained significant after adjusting for confounders. Age, marital status, and gender were significantly associated with various QoL dimensions. The findings indicate that methadone patients reported higher QoL in the social and physical domains in comparison with buprenorphine group, which contrasts with previous studies in other countries. These results highlight the potential impact of cultural context on QoL outcomes for individuals with OUD and provide a basis for future research and development of optimized, culturally sensitive treatment strategies within harm reduction frameworks in developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.